Cholinergic deficit induced memory retrieval impairment and hippocampal CaMKII-alpha deregulation is counteracted by sub-chronic agmatine treatment in mice-Reference-Cited by-同舟云学术

Cholinergic deficit induced memory retrieval impairment and hippocampal CaMKII-alpha deregulation is counteracted by sub-chronic agmatine treatment in mice

Published:2023-09-21 Issue:12 Volume:45 Page:1091-1099
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Ostovan Vahid Reza¹²,Baberi Nahid¹²,Farokhi Majid Reza³,Moezi Leila⁴,Pirsalami Fatema⁴,Soukhaklari Roksana⁵,Moosavi Maryam⁶^ORCID

Affiliation:

1. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2. Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran

3. Shiraz Neuroscience Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

4. Department of Pharmacology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

5. Department of Cardiology, Medical University of Graz, Graz, Austria

6. Nanomedicine and Nanobiology Research Center, Mohammad Rasoolullah (PBUH) Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran

Funder

Shiraz University of Medical Sciences, shiraz, Iran

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2023.2257417

Reference50 articles.

1. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment

2. Role of Cholinergic Signaling in Alzheimer’s Disease

3. Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy

4. Aging without Dementia is Achievable: Current Evidence from Epidemiological Research

5. Current and Future Treatments in Alzheimer Disease: An Update